In Vitro and In Vivo Assessments of Cardiovascular Effects with Omadacycline

Por Tanaka, S. Ken, Villano, Stephen
Publicado no Antimicrob Agents Chemother (2016)

Alterações neurofisiológicas durante a prática de meditação /

Por Tanaka, Guaraci Ken., Peressutti, Caroline, Universidade Federal do Rio de Janeiro.
Publicado em 2013

Alterações eletroencefalográficas durante a prática de meditação mindfulness /

Por Tanaka, Guaraci Ken, Velasques, Bruna Brandão, Universidade Federal do Rio de Janeiro.
Publicado em 2016

O karate como estratégia de desenvolvimento neurocognitivo em crianças de diferentes fases de maturação biológica /

Por Tanaka, Guaraci Ken, Velasques, Bruna Brandão, Universidade Federal do Rio de Janeiro.
Publicado em 2021

Effect of Food on the Bioavailability of Omadacycline in Healthy Participants

Por Tzanis, Evan, Manley, Amy, Villano, Stephen, Tanaka, S. Ken, Bai, Stephen, Loh, Evan
Publicado no J Clin Pharmacol (2016)

A Randomized, Evaluator-Blind, Phase 2 Study Comparing the Safety and Efficacy of Omadacycline to Those of Linezolid for Treatment of Complicated Skin and Skin Structure Infections

Por Noel, Gary J., Draper, Michael P., Hait, Howard, Tanaka, S. Ken, Arbeit, Robert D.
Publicado em 2012

In Vitro and In Vivo Activity of Omadacycline against Two Biothreat Pathogens, Bacillus anthracis and Yersinia pestis

Por Steenbergen, Judith, Tanaka, S. Ken, Miller, Lynda L., Halasohoris, Stephanie A., Hershfield, Jeremy R.
Publicado no Antimicrob Agents Chemother (2017)

Pharmacokinetics, Distribution, Metabolism, and Excretion of Omadacycline following a Single Intravenous or Oral Dose of (14)C-Omadacycline in Rats

Por Lin, Wen, Flarakos, Jimmy, Du, Yancy, Hu, Wenyu, He, Handan, Mangold, James, Tanaka, S. Ken, Villano, Stephen
Publicado no Antimicrob Agents Chemother (2016)

Electrophysiological Correlates of Long-Term Soto Zen Meditation

Por Pasquini, Henrique Adam, Tanaka, Guaraci Ken, Basile, Luis Fernando Hindi, Velasques, Bruna, Lozano, Mirna Delposo, Ribeiro, Pedro
Publicado no Biomed Res Int (2015)

Molecular Typing of Helicobacter pylori Isolates from a Multicenter U.S. Clinical Trial by ureC Restriction Fragment Length Polymorphism

Por Shortridge, Virginia D., Stone, Gregory G., Flamm, Robert K., Beyer, Jill, Versalovic, James, Graham, David Y., Tanaka, S. Ken
Publicado em 1998

Randomized, Open-Label Study of the Pharmacokinetics and Safety of Oral and Intravenous Administration of Omadacycline to Healthy Subjects

Por Sun, Haiying, Ting, Lillian, Machineni, Surendra, Praestgaard, Jens, Kuemmell, Andreas, Stein, Daniel S., Sunkara, Gangadhar, Kovacs, Steven J., Villano, Stephen, Tanaka, S. Ken
Publicado no Antimicrob Agents Chemother (2016)

Comparison of Omadacycline and Tigecycline Pharmacokinetics in the Plasma, Epithelial Lining Fluid, and Alveolar Cells of Healthy Adult Subjects

Por Gotfried, Mark H., Horn, Karolyn, Garrity-Ryan, Lynne, Villano, Stephen, Tzanis, Evan, Chitra, Surya, Manley, Amy, Tanaka, S. Ken, Rodvold, Keith A.
Publicado no Antimicrob Agents Chemother (2017)

Structure-Activity Relationship of the Aminomethylcyclines and the Discovery of Omadacycline

Por Honeyman, Laura, Ismail, Mohamed, Nelson, Mark L., Bhatia, Beena, Bowser, Todd E., Chen, Jackson, Mechiche, Rachid, Ohemeng, Kwasi, Verma, Atul K., Cannon, E. Pat, Macone, Ann, Tanaka, S. Ken, Levy, Stuart
Publicado no Antimicrob Agents Chemother (2015)

N-hydroxybenzimidazole Inhibitors of the Transcription Factor LcrF in Yersinia: Novel Anti-Virulence Agents

Por Kim, Oak K., Garrity-Ryan, Lynne K., Bartlett, Victoria J., Grier, Mark C., Verma, Atul K., Medjanis, Gabriel, Donatelli, Janice E., Macone, Ann B., Tanaka, S. Ken, Levy, Stuart B., Alekshun, Michael N.
Publicado em 2009

Effortless Attention as a Biomarker for Experienced Mindfulness Practitioners

Por Tanaka, Guaraci Ken, Maslahati, Tolou, Gongora, Mariana, Bittencourt, Juliana, Lopez, Luiz Carlos Serramo, Demarzo, Marcelo Marcos Piva, Budde, Henning, Teixeira, Silmar, Basile, Luis Fernando, Campayo, Javier Garcia, Cagy, Mauricio, Ribeiro, Pedro, Velasques, Bruna
Publicado no PLoS One (2015)

Small Molecule Inhibitors of LcrF, a Yersinia pseudotuberculosis Transcription Factor, Attenuate Virulence and Limit Infection in a Murine Pneumonia Model

Por Garrity-Ryan, Lynne K., Kim, Oak K., Balada-Llasat, Joan-Miquel, Bartlett, Victoria J., Verma, Atul K., Fisher, Michael L., Castillo, Cynthia, Songsungthong, Warangkhana, Tanaka, S. Ken, Levy, Stuart B., Mecsas, Joan, Alekshun, Michael N.
Publicado em 2010